Literature DB >> 32700160

Management of unruptured intracranial aneurysms: correlation of UIATS, ELAPSS, and PHASES with referral center practice.

James Feghali1, Abhishek Gami1, Justin M Caplan1, Rafael J Tamargo1, Cameron G McDougall1, Judy Huang2,3.   

Abstract

Concordance between the Unruptured Intracranial Aneurysm Treatment Score (UIATS), Earlier Subarachnoid Hemorrhage, Location, Age, Population, Size, Shape (ELAPSS) score, and Population, Hypertension, Age, Size, Earlier Subarachnoid Hemorrhage, Site (PHASES) score with real-world management decisions in unruptured intracranial aneurysms (UIAs) remains unclear, especially in current practice. This study aimed to investigate this concordance, while developing an optimal model predictive of recent decision practices at a quaternary referral center. A prospective database of patients presenting with UIAs to our institution from January 1 to December 31, 2018, was used. Concordance between the scores and real-world management decisions on every UIA was assessed. Complications and length of stay (LOS) were compared between aneurysms in the UIATS-recommended treatment and observation groups. A subgroup analysis of concordance was also conducted among junior and senior surgeons. An optimal logistic regression model predictive of real-world decisions was also derived. The cohort consisted of 198 patients with 271 UIAs, of which 42% were treated. The UIATS demonstrated good concordance with an AUC of 0.765. Of the aneurysms in the UIATS-recommended "observation" group, 22% were discordantly treated. The ELAPSS score demonstrated good discrimination (AUC = 0.793), unlike the PHASES score (AUC = 0.579). Endovascular treatment rates, complications, and LOS were similar between aneurysms in the UIATS-recommended treatment and observation groups. Similar concordance was obtained among junior and senior surgeons. The optimal predictive model consisted of several significantly associated variables and had an AUC of 0.942. Cerebrovascular specialists may be treating aneurysms slightly more than these scores would recommend, independently of years in practice. Wide variation still exists in management practices of UIAs.

Entities:  

Keywords:  Decision making; Endovascular surgery; Intracranial aneurysm; Treatment

Year:  2020        PMID: 32700160     DOI: 10.1007/s10143-020-01356-6

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  28 in total

1.  A survey of intracranial aneurysm treatment practices among United States physicians.

Authors:  Kyle M Fargen; Hector E Soriano-Baron; Julia T Rushing; William Mack; J Mocco; Felipe Albuquerque; Andrew F Ducruet; Maxim Mokin; Italo Linfante; Stacey Q Wolfe; John A Wilson; Joshua A Hirsch
Journal:  J Neurointerv Surg       Date:  2017-02-09       Impact factor: 5.836

2.  PHASES Score for the Management of Intracranial Aneurysm: A Cross-Sectional Population-Based Retrospective Study.

Authors:  Philippe Bijlenga; Renato Gondar; Sabine Schilling; Sandrine Morel; Sven Hirsch; Johanna Cuony; Marco-Vincenzo Corniola; Fabienne Perren; Daniel Rüfenacht; Karl Schaller
Journal:  Stroke       Date:  2017-06-30       Impact factor: 7.914

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  ELAPSS score for prediction of risk of growth of unruptured intracranial aneurysms.

Authors:  Daan Backes; Gabriel J E Rinkel; Jacoba P Greving; Birgitta K Velthuis; Yuichi Murayama; Hiroyuki Takao; Toshihiro Ishibashi; Michiya Igase; Karel G terBrugge; Ronit Agid; Juha E Jääskeläinen; Antti E Lindgren; Timo Koivisto; Mikael von Und Zu Fraunberg; Shunji Matsubara; Junta Moroi; George K C Wong; Jill M Abrigo; Keiji Igase; Katsumi Matsumoto; Marieke J H Wermer; Marianne A A van Walderveen; Ale Algra; Mervyn D I Vergouwen
Journal:  Neurology       Date:  2017-03-31       Impact factor: 9.910

Review 5.  Unruptured intracranial aneurysms: development, rupture and preventive management.

Authors:  Nima Etminan; Gabriel J Rinkel
Journal:  Nat Rev Neurol       Date:  2016-11-03       Impact factor: 42.937

Review 6.  Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies.

Authors:  Jacoba P Greving; Marieke J H Wermer; Robert D Brown; Akio Morita; Seppo Juvela; Masahiro Yonekura; Toshihiro Ishibashi; James C Torner; Takeo Nakayama; Gabriël J E Rinkel; Ale Algra
Journal:  Lancet Neurol       Date:  2013-11-27       Impact factor: 44.182

Review 7.  Cavernous carotid aneurysms: to treat or not to treat?

Authors:  Christopher S Eddleman; Michael C Hurley; Bernard R Bendok; H Hunt Batjer
Journal:  Neurosurg Focus       Date:  2009-05       Impact factor: 4.047

8.  Multidisciplinary consensus on assessment of unruptured intracranial aneurysms: proposal of an international research group.

Authors:  Nima Etminan; Kerim Beseoglu; Daniel L Barrow; Joshua Bederson; Robert D Brown; E Sander Connolly; Colin P Derdeyn; Daniel Hänggi; David Hasan; Seppo Juvela; Hidetoshi Kasuya; Peter J Kirkpatrick; Neville Knuckey; Timo Koivisto; Giuseppe Lanzino; Michael T Lawton; Peter LeRoux; Cameron G McDougall; Edward Mee; J Mocco; Andrew Molyneux; Michael K Morgan; Kentaro Mori; Akio Morita; Yuichi Murayama; Shinji Nagahiro; Alberto Pasqualin; Andreas Raabe; Jean Raymond; Gabriel J E Rinkel; Daniel Rüfenacht; Volker Seifert; Julian Spears; Hans-Jakob Steiger; Helmuth Steinmetz; James C Torner; Peter Vajkoczy; Isabel Wanke; George K C Wong; John H Wong; R Loch Macdonald
Journal:  Stroke       Date:  2014-03-25       Impact factor: 7.914

Review 9.  Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening.

Authors:  Robert D Brown; Joseph P Broderick
Journal:  Lancet Neurol       Date:  2014-04       Impact factor: 44.182

10.  The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus.

Authors:  Nima Etminan; Robert D Brown; Kerim Beseoglu; Seppo Juvela; Jean Raymond; Akio Morita; James C Torner; Colin P Derdeyn; Andreas Raabe; J Mocco; Miikka Korja; Amr Abdulazim; Sepideh Amin-Hanjani; Rustam Al-Shahi Salman; Daniel L Barrow; Joshua Bederson; Alain Bonafe; Aaron S Dumont; David J Fiorella; Andreas Gruber; Graeme J Hankey; David M Hasan; Brian L Hoh; Pascal Jabbour; Hidetoshi Kasuya; Michael E Kelly; Peter J Kirkpatrick; Neville Knuckey; Timo Koivisto; Timo Krings; Michael T Lawton; Thomas R Marotta; Stephan A Mayer; Edward Mee; Vitor Mendes Pereira; Andrew Molyneux; Michael K Morgan; Kentaro Mori; Yuichi Murayama; Shinji Nagahiro; Naoki Nakayama; Mika Niemelä; Christopher S Ogilvy; Laurent Pierot; Alejandro A Rabinstein; Yvo B W E M Roos; Jaakko Rinne; Robert H Rosenwasser; Antti Ronkainen; Karl Schaller; Volker Seifert; Robert A Solomon; Julian Spears; Hans-Jakob Steiger; Mervyn D I Vergouwen; Isabel Wanke; Marieke J H Wermer; George K C Wong; John H Wong; Gregory J Zipfel; E Sander Connolly; Helmuth Steinmetz; Giuseppe Lanzino; Alberto Pasqualin; Daniel Rüfenacht; Peter Vajkoczy; Cameron McDougall; Daniel Hänggi; Peter LeRoux; Gabriel J E Rinkel; R Loch Macdonald
Journal:  Neurology       Date:  2015-08-14       Impact factor: 9.910

View more
  1 in total

1.  Increased Levels of Serum IL-15 and TNF-β Indicate the Progression of Human Intracranial Aneurysm.

Authors:  Shuzhe Yang; Qingyuan Liu; Junhua Yang; Jun Wu; Shuo Wang
Journal:  Front Aging Neurosci       Date:  2022-06-17       Impact factor: 5.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.